“We are proud to announce the acquisition of Roplan and Steridose by IDEX Corporation from FSN Capital Partners”, says Peter Schmid, CEO of Velcora.“The Roplan and Steridose companies complement both IDEX Sealing Solutions as well as Health and Sciences platforms well,” says IDEX Chairman and CEO Andy Silvernail. He continues: “In our unique structure, companies retain a great deal of autonomy, while benefitting from the expertise and operating model at IDEX. Roplan and Steridose should flourish as part of our culture, where great teams win together by focusing on the things that matter most, combined with an obsession on solving our customers’ most challenging problems.”
IDEX is a global fluidics leader serving high growth specialized markets and are best known for expertise in highly engineered fluidics systems and components, as well as for expertise in fire and safety products including the Jaws of Life® family of rescue and recovery IDEX products touch lives every day. Whether it’s a life-saving rescue operation, dispensing fresh juice to a first grader or fueling aircraft, IDEX is a leader in creating enabling technology used in many of the most common everyday activities.
IDEX shares are traded on the New York Stock Exchange under the symbol “IEX.”
For more information, please visit www.idexcorp.com.